91399 - Personalising prostate cancer care - Current treatment options
- : Online
Online learning module with an original peer-reviewed update on current treatment options for managing prostate cancer
Relevance to General Practice
- Treatment for men with prostate cancer can now be tailored according to patient, tumour, imaging and genetic factors.
- Many patients with low-risk Gleason 6 prostate cancer (International Society of Urological Pathology [ISUP] grade group 1) do not require treatment and can instead be safely monitored. Criteria for offering
active surveillance rather than definitive treatment to men has been updated.
- Active surveillance may allow up to 50% of patients to avoid unnecessary treatment.
- Studies have found that 10 to 30% of patients (10% of modern well-assessed patients) on active surveillance programs required treatment over a 15-year period, because of either disease progression or patient preference.8
- Identify men with prostate cancer who are suitable for active surveillance
- Participate in active surveillance of men with prostate cancer
- Discuss with patients treatment options for prostate cancer and their side effects
- Take steps to make men more comfortable during intimate examinations